Laura Beuls advises clients on all aspects of European competition law, with specific experience in multijurisdictional merger control filings and behavioral cases. Her experience covers several industry sectors including technology, entertainment, and e-commerce.
Prior to joining Arnold & Porter in 2021, Laura worked at a leading U.S. law firm in Brussels. She also worked as a trainee at the Directorate General for Competition of the European Commission, where she focused on the assessment of mergers in the sectors of financial services, pharmaceuticals and chemicals.
Experience
- Pfizer in its $43 billion acquisition of Seagen Inc., a world-leader in antibody-drug conjugates (ADCs).
- Pfizer in its US$6.7 billion acquisition of Arena Pharmaceuticals before competition authorities worldwide.
- Boston Scientific in obtaining merger control and foreign investment clearances in relation to its proposed acquisition of Baylis Medical Company Inc.
Perspectives
April 2, 2024
EU Sanctions: Ensuring Compliance With the New "No Re-Export to Russia" Clause
Advisory
Credentials
Education
- LL.M., Competition Law, King's College London, 2020, distinction
- Master in Management, HEC Liège Management School - University of Liège, 2019, cum laude
- Master in Law, University of Liège, 2018, magna cum laude
- Bachelor in Law, University of Liège, 2016, cum laude
Admissions
- Brussels, Belgium
Languages
- French
- English
- Dutch